Why Renaming PCOS Could Help 170 Million Women Worldwide

More than 170 million women worldwide suffer from PCOS, or polycystic ovary syndrome. Rochelle Lewis is one of them and believes that changing the disease's name could improve women's access to treatment and reduce stigma.

Polycystic ovary syndrome, known by the acronym PCOS, affects more than 170 million women worldwide – yet this condition often remains undiagnosed and misunderstood. Rochelle Lewis is one of many women who has received this diagnosis and who believes that changing the disease's name could help women access better treatment.

The problem is that the name PCOS primarily points to the ovaries and cysts, but in reality it is a complex hormonal disorder that affects much more – including metabolism, fertility, mood and heart health. Many experts believe that the misleading name hinders both timely diagnosis and public understanding.

Advocates for renaming argue that a more accurate name would help doctors identify the disease more quickly and reduce the stigma that falls on women. They also hope that a clearer name would bring increased investment in research and the development of treatment options.

The experiences of women like Rochelle Lewis highlight a deeper problem: women's health concerns are often taken less seriously and left unanswered for too long. Changing one disease's name will not solve all problems, but it can be an important step toward ensuring that women's health concerns receive the attention they deserve.